Selpercatinib, sold under the brand name Retevmo among others, is a medication for the treatment of cancers in people whose tumors have an alteration in a specific gene. Reference standards of Selpercatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Selpercatinib
Catalogue No.:PA 19 1960000
CAS :
Molecular Formula : C16H14ClN3O
Molecular Weight : 525.61
tert-Butyl 3-(5-(3-cyano-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridin-4-yl)pyridin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate
Catalogue No.:PA 19 1961000
Molecular Formula : C27H32N6O4
Molecular Weight : 504.59
4-(6-(3,6-Diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile
Catalogue No.:PA 19 1961001
Molecular Formula : C22H24N6O2
Molecular Weight : 404.47
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
